Cargando…
Making progress in a rare disease: emerging therapeutics in soft tissue sarcomas
Sarcomas are rare tumors derived from mesenchymal connective tissues in the body. Because there are well over 50 histologic sarcoma subtypes, including malignant and non-malignant pathologies, clinical courses and therapeutic management are widely divergent. In general, therapeutic options across al...
Autores principales: | Choe, Jennifer, Riedel, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221061/ https://www.ncbi.nlm.nih.gov/pubmed/30450193 http://dx.doi.org/10.12688/f1000research.15868.1 |
Ejemplares similares
-
Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies
por: de Bree, Eelco, et al.
Publicado: (2023) -
Systemic Therapy for Advanced Soft Tissue Sarcomas
por: Riedel, Richard F
Publicado: (2012) -
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019) -
Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
por: Sadri, Navid, et al.
Publicado: (2013) -
A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)